ExtendedPhrase etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
ExtendedPhrase etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

13 Haziran 2014 Cuma

3D printed prosthetics: extended-phrase hope for amputees in South Sudan

Mick Ebling in South Sudan

Mick Ebeling brought two 3D printers to the Nuba Mountains in South Sudan to print limbs for war amputees. Photograph: Timoteo




In November 2013 Mick Ebeling left his property in Venice Seashore, California for the Nuba Mountains in South Sudan. His aim? To meet a younger double amputee named Daniel Omar and print him a prosthetic arm.


Given that then, Undertaking Daniel has been covered by significantly of the world’s media, so when we caught up with the entrepreneur, we were keen to know what affect the innovation is obtaining in Sudan Sudan and how Ebeling’s background in promoting is informing his efforts to use ‘technology for the sake of humanity’.


What motivated you to travel to South Sudan?


We come from the school of open source that believes that units like this need to be readily accessible to everybody. We taught a group of eight younger males to proceed undertaking the function and we left a massive box of filament and supplies and two 3D printers.


It took me about four days to get back from South Sudan, and when I acquired property I looked at my e mail and had images of two arms that were produced while we have been in the air. Naturally, Daniel feeding himself for the initial time in two many years was an incredible success, but seeing that this was sustainable, that was the most thrilling.


How sturdy are the limbs?


They truly are quite resilient. But since they are modular – you print out the knuckle, finger and palm individually – if one thing breaks, you just print it yet again. With an expensive prosthetic when something breaks you have to send it back to the manufacturer. And there is no post in the Nuba Mountains. That is one particular of the factors why this resolution is so fantastic, something can break and you’re not valuable about.


What is the funding model of your organisation, Not Impossible Labs? I read that you began off as a basis but now you happen to be for profit working with huge brands in an modern way


We began off Not Unattainable as a non-revenue and I joked that I was going deaf by the sound of the rattling of the tin cups. As a non-profit you are restricted by the whims and trends in providing. I did not want to be governed by trends, I wanted to be governed by what we desired to accomplish.


I transfered my experience as a commercial producer functioning with marketing companies. My belief is the much more folks that know about the stories that we have produced, the a lot more likelihood it truly is going to get implemented. We realised that if we get in touch with the most strong entities in the world – brand names and corporations – and work with what they previously do – develop messages close to their brand names – we can aid every other.


How does that operate in practice?


We spouse with manufacturers who have items and items and companies that make sense with our initiative. Intel and Precipart were two manufacturers that came in to underwrite Undertaking Daniel. In return they received content. They received a webfilm that they were in a position to consider out and market. They have been looking for stories to tell. Alternatively of an advert about the attributes of the solution, they acquired a potent message. The brand wins because they get acknowledged for supporting something excellent. We’re just fitting into a branding and messaging program that previously exists inside the corporate world, that ethically and organically fulfills what we want.


Are there any corporations you would not work with?


We’re not previous enough yet to encounter any ethical crossroads of what to do or not to do, but we want to operate with businesses who want to do excellent in the planet.

Do you believe your project provides any lessons for other improvement organisations?


A great deal of the NGOs above there are undertaking great work and a lot of them are bogged down by the bureaucracy of a enormous organisation. If you can implement something that overcomes that then you’re previously ahead of the game. Our purpose is for folks to be inspired by the open supply mentality of empowering and equipping people to help themselves. 3D printing puts the power into the hands of the folks on the ground. After you educate individuals on what a particular issue can do, they will often make it do anything much more.


What is the up coming challenge you are tackling?


We’re searching at taking 3D printers to Nicaragua, Vietnam, Cambodia, Colombia, Sierra Leone – spots that reached out to us. And we’re working on a undertaking right now in Mexico that’s going to help children with cerebral palsy, muscular dystrophy or a number of sclerosis to walk once more.


Read far more stories like this:


• Marketing: still the dirty word of advancement?


• Leading ideas on making use of the media to aid growth


• DIY biotech: how to develop your self a minimal-expense malaria detector


Join the neighborhood of worldwide development specialists and specialists. Become a GDPN member to get a lot more stories like this direct to your inbox




3D printed prosthetics: extended-phrase hope for amputees in South Sudan

30 Mart 2014 Pazar

Survival Benefit Found Following Extended-Phrase Resynchronization Therapy

MADIT-CRT was an influential trial that showed a reduction in heart failure complications — but not mortality — when cardiac resynchronization treatment (CRT) was extra to an implantable defibrillator in individuals with mild heart failure who also had left bundle-branch block (LBBB). Individuals in the trial were followed for two.four years, raising queries about the long-term effects of CRT. Now, a 2nd seem at 854 sufferers who participated in a stick to-up examine, presented at the American College of Cardiology and published in the New England Journal of Medication, suggests that over the lengthy phrase, CRT may save lives in this population. MADIT-CRT was sponsored by Boston Scientific.


All round, there was a highly significant 41% reduction in death (P=.001) connected with CRT therapy in the massive subgroup of sufferers with LBBB. The mortality fee was distinct right after 1 yr and remained important all through follow-up. At 7 many years, the mortality charge was 29% in the management group versus 18% in the CRT group. There was an even larger variation in nonfatal heart failure events (P&lt0.001). The positive aspects have been remarkably constant across a broad assortment of subgroups.


However, the group of MADIT-CRT individuals who did not have LBBB showed no reduction in either mortality or heart failure events related with CRT. The authors wrote that this “lack of benefit of CRT in individuals with no left bundle-branch block was steady, regardless of the QRS duration or ECG morphologic findings with respect to proper bundle-branch block and an intraventricular conduction delay. As a result, at present, our information do not help early intervention with CRT in any subset of this population.”


In an accompanying editorial, Jeffrey Goldberger writes that the outcomes should serve “as a strong impetus to pursue CRT in patients with mild heart failure with decreased ejection fraction and left bundle-branch block.”


Arthur Moss, responding in CardioExchange to a query from John Ryan, mentioned the 2013 heart failure tips, which advocate CRT for non-LBBB individuals with a QRS duration of &gt150 msec, demands to be revised.



Survival Benefit Found Following Extended-Phrase Resynchronization Therapy

26 Mart 2014 Çarşamba

How A New Alzheimer"s Test Could Kill Extended-Phrase Care Insurance -- Or Make It Cheaper

A crew of researchers at Georgetown University and six other healthcare centers has created a easy blood test  they say can predict, with 90 percent accuracy, whether an person will build Alzheimer’s Ailment within two-3 many years.  If it operates as advertised, such a check could have a profound effect on the lengthy-term care insurance market place.


The examine outcomes, published in the journal Nature Medicine, are really preliminary. If the check operates as hoped, it has massive possible benefits, which includes the potential to advance efforts to find a treatment for the condition. If it tends to make early intervention feasible, this check could dramatically decrease extended-phrase care expenses.


But it also has a effective unintended consequence: It could destroy private prolonged-term care insurance coverage or even any potential voluntary government insurance coverage system. A widely obtainable check to predict Alzheimer’s would make any kind of voluntary extended-term care insurance impossible. “It would be a massive game changer,” a single insurance actuary informed me.


Here’s why: If you consider the check and discover you are virtually certain to build cognitive impairment, you are far more likely to get lengthy-phrase care insurance coverage.


If insurers have entry to the check outcomes, they will either deny you coverage or charge you considerably larger premiums than a person whose benefits are damaging.


But even if insurers are not allowed to see the benefits (and federal law currently prohibits overall health insurers from demanding benefits of certain health care tests), a low cost and accurate Alzheimer’s check still could sink the voluntary insurance coverage model.  Insurers would just presume that buyers know they are very likely to contract the illness and they’d raise premiums sharply to account for that. The result: the traditional insurance death spiral.


Already more than half of all LTC insurance coverage claims are for cognitive impairment. And surveys demonstrate that those who believe they are going to contract Alzheimer’s (even with no an correct test) are far far more likely to buy than individuals who do not.


There are large uncertainties here. First, the Georgetown analysis was very preliminary with a small sample. Much far more demands to be completed just before the check can be commercialized. 2nd, 2-three years advance warning is probably not enough to make considerably difference for insurance customers. Individuals usually buy in their 50s or early 60s and most won’t show symptoms of Alzheimer’s for twenty years.


However, Howard J. Federoff, executive vice president of wellness sciences at Georgetown University Healthcare Center and an writer of the review, says his crew desires to know if their check can determine biological changes even sooner. In a current interview with the radio program Science Friday, he stated his group had currently begun designing that adhere to-up study.


The test identifies changes in blood cells that predict improvement of cognitive impairment. Other researchers are hunting at approaches to identify regardless of whether an individual has a genetic predisposition to cognitive condition. If any of people tests pan out, the effect on LTC insurance would be even far more profound given that genetic markers could be identified at a extremely youthful age.


For now, this new study promises a possibly potent diagnostic instrument.


In the greatest situation, it would support other people produce an successful way to treat—or even prevent—Alzheimer’s. Until finally now, drug therapies aimed at treating this illness have been deeply disappointing. But Federoff wonders whether that’s simply because these medicines are getting provided too late. He asks no matter whether sufferers would advantage by acquiring the meds just before they start showing signs and symptoms. His test could make that possible.


But there is a probably profound downside. What takes place if folks discover they are fated to suffer cognitive impairment and, as a consequence of that knowledge, shed accessibility to one particular of the couple of resources available to pay out for what they know will be really expensive care? As analysis into these kinds of predictive tests continues, it is a question we require to maintain asking.



How A New Alzheimer"s Test Could Kill Extended-Phrase Care Insurance -- Or Make It Cheaper